Related Experiment Video
Updated: Jan 1, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Pulmonary non-tuberculous mycobacterial infections: current state and future management
Kai Ling Chin1, Maria E Sarmiento2, Nadine Alvarez-Cabrera3
1Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah (UMS), Kota Kinabalu, Sabah, Malaysia. chinkl@ums.edu.my.
Abstract:
Currently, there is a trend of increasing incidence in pulmonary non-tuberculous mycobacterial infections (PNTM) together with a decrease in tuberculosis (TB) incidence, particularly in developed countries. The prevalence of PNTM in underdeveloped and developing countries remains unclear as there is still a lack of detection methods that could clearly diagnose PNTM applicable in these low-resource settings. Since non-tuberculous mycobacteria (NTM) are environmental pathogens, the vicinity favouring host-pathogen interactions is known as important predisposing factor for PNTM. The ongoing changes in world population, as well as socio-political and economic factors, are linked to the rise in the incidence of PNTM. Development is an important factor for the improvement of population well-being, but it has also been linked, in general, to detrimental environmental consequences, including the rise of emergent (usually neglected) infectious diseases, such as PNTM. The rise of neglected PNTM infections requires the expansion of the current efforts on the development of diagnostics, therapies and vaccines for mycobacterial diseases, which at present, are mainly focused on TB. This review discuss the current situation of PNTM and its predisposing factors, as well as the efforts and challenges for their control.
Insights
Pulmonary non-tuberculous mycobacterial infections (PNTM) are increasing globally, especially in developed nations. Addressing these neglected infections requires improved diagnostics, therapies, and vaccines beyond current tuberculosis efforts.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Rising incidence of pulmonary non-tuberculous mycobacterial infections (PNTM) contrasts with declining tuberculosis (TB) rates, particularly in developed countries.
- Prevalence of PNTM in low-resource settings is largely unknown due to a lack of suitable diagnostic methods.
- Environmental exposure and host-pathogen interactions are key predisposing factors for PNTM.
Purpose of the Study:
- To review the current epidemiology and predisposing factors of PNTM.
- To discuss the challenges and ongoing efforts in controlling PNTM.
- To highlight the need for expanded research and development for neglected mycobacterial diseases.
Main Methods:
- Literature review of current trends in PNTM and TB incidence.
- Analysis of factors contributing to PNTM emergence, including environmental and socio-economic aspects.
- Discussion of diagnostic, therapeutic, and vaccine development efforts for mycobacterial diseases.
Main Results:
- Increasing global incidence of PNTM, with a concurrent decrease in TB.
- Identification of environmental proximity and population changes as drivers of PNTM.
- Significant gaps in PNTM diagnostics and control strategies, especially in developing regions.
Conclusions:
- PNTM represents a growing global health concern, often overlooked compared to TB.
- Development and environmental changes contribute to the rise of PNTM.
- Urgent need for enhanced diagnostics, treatments, and vaccines for PNTM is emphasized.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

